Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $73.29.
Several research firms have weighed in on NHI. Bank of America started coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price on the stock. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price objective for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Truist Financial upped their target price on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Finally, StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th.
Read Our Latest Research Report on National Health Investors
Institutional Trading of National Health Investors
National Health Investors Trading Up 0.5 %
NYSE:NHI opened at $77.74 on Monday. The company has a market capitalization of $3.53 billion, a P/E ratio of 26.71, a P/E/G ratio of 5.19 and a beta of 1.05. The stock’s 50 day moving average price is $80.08 and its 200 day moving average price is $74.05. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. National Health Investors has a 52 week low of $51.59 and a 52 week high of $86.13.
National Health Investors (NYSE:NHI – Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.42). The business had revenue of $63.32 million for the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.08 EPS. On average, research analysts forecast that National Health Investors will post 4.42 EPS for the current fiscal year.
National Health Investors Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.63%. National Health Investors’s dividend payout ratio (DPR) is presently 123.71%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Stories
- Five stocks we like better than National Health Investors
- How Can Investors Benefit From After-Hours Trading
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Profitably Trade Stocks at 52-Week Highs
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.